Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: BMcV who wrote (1854)	2/26/1999 6:13:00 PM
From: j_fir2	Read Replies (1) \| Respond to of 10280

>>up six as I speak>> I love this stock! And hate the rumor on Yahoo thread (again!) about buyout by J&J. Makes taking $200/share sound like a bad deal. Thanks all for the good discussion! 'fir

To: BMcV who wrote (1854)	2/28/1999 12:59:00 AM
From: Neuroguy	Read Replies (1) \| Respond to of 10280

Bruce - ICEs and side effects Bruce - you're correct that the therapeutic effects of some compounds like Prozac will be unseparable from their side effects. Hope people enjoyed my Yahoo spiel about sexual dysfunction! To borrow a phrase from Michelle Pfeiffer in Up Close and Personal, I tried to "put the fun in dysfunction"! But jokes aside, it should be borne in mind that the 'stripped isomer' of Prozac is patented by SEPR also for it's own therapeutic uses, I believe (correct me if I'm wrong). And in the case of the other 39 or so other drugs they have in the pipe, the stripped isomer will not, in some of those cases, carry some of the unwanted side effects. So SEPR's approach has not only garnered them useful patents, but in many cases the separated isomer will actually produce a better drug. The situation isn't quite as simple as Southwell presented on CNBC, but in some cases, it may be close. I didn't repeat that sexual dysfunction 'essay' over here, simply because most of you here appear to read the Yahoo thread also. Neurodude